About SIDAM
SIDAM is a company based in Mirandola (Italy) founded in 1991 by Graziano Azzolini was acquired by Mandarin Capital Partners in September 2020. SIDAM offers products and services including Pressure Measurement Devices, Infusion Systems, and Radiology Devices. SIDAM operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Mirandola, Italy
- Founders Graziano Azzolini
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sidam S.R.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$386.15 K (USD), Grant
Dec 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
Mandarin Capital Partners
(Sep 03, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SIDAM
SIDAM offers a comprehensive portfolio of products and services, including Pressure Measurement Devices, Infusion Systems, and Radiology Devices.
Tools for monitoring esophageal and intradominal pressure in intensive care.
IV-sets for specific therapies like pain management.
Devices for contrast transfer in CT, MR, and angiography.
Funding Insights of SIDAM
Investors in SIDAM
SIDAM has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Mandarin Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for SIDAM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SIDAM
Investment portfolio details for SIDAM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SIDAM
Detailed financials for SIDAM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sidam Comparisons
Peer comparison for SIDAM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SIDAM
SIDAM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of SIDAM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sidam
Complete news archive for SIDAM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SIDAM
SIDAM was founded in 1991 and raised its 1st funding round 29 years after it was founded.
SIDAM is headquartered in Mirandola, Italy. It is registered at Mirandola, Emilia-romagna, Italy.
SIDAM was established in 1991 in Mirandola, Italy, within the medical devices sector. Infusion systems are produced for hospital applications. Medical devices such as the Nutrient and electromedical equipment like the Optivent are manufactured for resuscitation departments. Disposable medical devices, electromedical equipment, and thermostatic cells are created for imaging diagnostics, supporting clinical operations across these areas.
SIDAM's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
SIDAM offers Pressure Measurement Devices, Infusion Systems, and Radiology Devices.
SIDAM has 2 investors. Key investors include European Union, and Mandarin Capital Partners.